Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs. Issue 15 (1st August 2017)
- Record Type:
- Journal Article
- Title:
- Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs. Issue 15 (1st August 2017)
- Main Title:
- Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs
- Authors:
- Špaček, Petr
Keough, Dianne T.
Chavchich, Marina
Dračínský, Martin
Janeba, Zlatko
Naesens, Lieve
Edstein, Michael D.
Guddat, Luke W.
Hocková, Dana - Abstract:
- Graphical abstract: Abstract: Two new series of symmetric acyclic nucleoside bisphosphonates (ANbPs) have been synthesised as potential inhibitors of the Plasmodium falciparum ( Pf ) and vivax ( Pv ) 6-oxopurine phosphoribosyltransferases . The structural variability between these symmetric ANbPs lies in the number of atoms in the two acyclic linkers connecting the N 9 atom of the purine base to each of two phosphonate groups and the branching point of the acyclic moiety relative to the purine base, which occurs at either the alpha or beta positions. Within each series, six different 6-oxopurine bases have been attached. In general, the ANbPs with either guanine or hypoxanthine have lower Ki values than for those containing either the 8-bromo or 7-deaza 6-oxopurine bases. The lowest Ki values obtained for the two parasite enzymes were 0.1 μM ( Pf ) and 0.2 μM ( Pv ) for this series of compounds. Two phosphoramidate prodrugs of these inhibitors exhibited antimalarial activity against Pf in infected erythrocyte cell culture with IC50 values of 0.8 and 1.5 μM. These two compounds exhibited low cytotoxicity in human A549 cells having CC50 values of >300 μM resulting in an excellent selectivity index.
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 25:Issue 15(2017)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 25:Issue 15(2017)
- Issue Display:
- Volume 25, Issue 15 (2017)
- Year:
- 2017
- Volume:
- 25
- Issue:
- 15
- Issue Sort Value:
- 2017-0025-0015-0000
- Page Start:
- 4008
- Page End:
- 4030
- Publication Date:
- 2017-08-01
- Subjects:
- Malaria -- Acyclic nucleoside phosphonates -- Bisphosphonates -- Phosphoramidate prodrug -- Hypoxanthine–guanine-[xanthine] phosphoribosyltransferase
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2017.05.048 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 655.xml